# Robert Molpus – FDA Inspection, Apr 3, 2025

Source: https://www.keypedia.com/records/fda_inspections/robert-molpus/a3a7a1cc-83dc-432d-807c-b450bc9d442a
Source feed: FDA_Inspections

> FDA inspection 1266065 of Robert Molpus, April 03, 2025. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266065
- Company Name: Robert Molpus
- Inspection Date: 2025-04-03
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1127812 - 2020-08-10
- FDA Inspection 1039869 - 2018-01-26

## Related Officers

- [Company Rep](https://www.keypedia.com/people/emily-c-caldwell/101868aa-0586-4d37-8bc6-194f43d66cb7)

Company: https://www.keypedia.com/companies/robert-molpus/85c57cdc-e62c-46e2-83e4-a4c22ae846ad

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c